Sage Therapeutics Inc (SAGE)
14.00
+1.05
(+8.11%)
USD |
NASDAQ |
Apr 24, 16:00
14.00
0.00 (0.00%)
After-Hours: 20:00
Sage Therapeutics 1 Year Total Returns (Daily): -70.35% for April 24, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 24, 2024 | -70.35% |
April 23, 2024 | -72.73% |
April 22, 2024 | -72.85% |
April 19, 2024 | -71.90% |
April 18, 2024 | -72.77% |
April 17, 2024 | -72.54% |
April 16, 2024 | -64.45% |
April 15, 2024 | -65.16% |
April 12, 2024 | -63.94% |
April 11, 2024 | -61.76% |
April 10, 2024 | -60.29% |
April 09, 2024 | -60.18% |
April 08, 2024 | -59.99% |
April 05, 2024 | -59.63% |
April 04, 2024 | -59.21% |
April 03, 2024 | -59.35% |
April 02, 2024 | -58.89% |
April 01, 2024 | -57.34% |
March 28, 2024 | -55.15% |
March 27, 2024 | -56.11% |
March 26, 2024 | -56.61% |
March 25, 2024 | -56.44% |
March 22, 2024 | -54.27% |
March 21, 2024 | -53.87% |
March 20, 2024 | -55.25% |
Date | Value |
---|---|
March 19, 2024 | -54.90% |
March 18, 2024 | -54.69% |
March 15, 2024 | -53.90% |
March 14, 2024 | -55.02% |
March 13, 2024 | -52.47% |
March 12, 2024 | -48.56% |
March 11, 2024 | -46.46% |
March 08, 2024 | -50.27% |
March 07, 2024 | -47.56% |
March 06, 2024 | -49.80% |
March 05, 2024 | -49.20% |
March 04, 2024 | -47.91% |
March 01, 2024 | -47.77% |
February 29, 2024 | -48.42% |
February 28, 2024 | -45.85% |
February 27, 2024 | -44.62% |
February 26, 2024 | -44.55% |
February 23, 2024 | -47.09% |
February 22, 2024 | -47.26% |
February 21, 2024 | -48.05% |
February 20, 2024 | -51.30% |
February 16, 2024 | -48.36% |
February 15, 2024 | -43.67% |
February 14, 2024 | -42.68% |
February 13, 2024 | -49.16% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.96%
Minimum
Apr 03 2020
200.2%
Maximum
Apr 05 2021
-15.64%
Average
-24.64%
Median
Dec 31 2019
1 Year Total Returns (Daily) Benchmarks
Biogen Inc | -31.07% |
Perspective Therapeutics Inc | 160.0% |
Vanda Pharmaceuticals Inc | -27.16% |
ADMA Biologics Inc | 87.79% |
Finch Therapeutics Group Inc | -84.35% |